BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35681511)

  • 1. LSD1 Inhibition Enhances the Immunogenicity of Mesenchymal Stromal Cells by Eliciting a dsRNA Stress Response.
    Mardani F; Saad W; El-Hachem N; Bikorimana JP; Kurdi M; Shammaa R; Talbot S; Rafei M
    Cells; 2022 Jun; 11(11):. PubMed ID: 35681511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UM171A-induced ROS promote antigen cross-presentation of immunogenic peptides by bone marrow-derived mesenchymal stromal cells.
    Salame N; Bikorimana JP; El-Hachem N; Saad W; Kurdi M; Zhao J; Eliopoulos N; Shammaa R; Rafei M
    Stem Cell Res Ther; 2022 Jan; 13(1):16. PubMed ID: 35012668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade.
    Sheng W; LaFleur MW; Nguyen TH; Chen S; Chakravarthy A; Conway JR; Li Y; Chen H; Yang H; Hsu PH; Van Allen EM; Freeman GJ; De Carvalho DD; He HH; Sharpe AH; Shi Y
    Cell; 2018 Jul; 174(3):549-563.e19. PubMed ID: 29937226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tying up tranylcypromine: Novel selective histone lysine specific demethylase 1 (LSD1) inhibitors.
    Ji YY; Lin SD; Wang YJ; Su MB; Zhang W; Gunosewoyo H; Yang F; Li J; Tang J; Zhou YB; Yu LF
    Eur J Med Chem; 2017 Dec; 141():101-112. PubMed ID: 29031059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New tranylcypromine derivatives containing sulfonamide motif as potent LSD1 inhibitors to target acute myeloid leukemia: Design, synthesis and biological evaluation.
    Liang L; Wang H; Du Y; Luo B; Meng N; Cen M; Huang P; Ganesan A; Wen S
    Bioorg Chem; 2020 Jun; 99():103808. PubMed ID: 32334189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tranylcypromine, a lysine-specific demethylase 1 (LSD1) inhibitor, suppresses lesion growth and improves generalized hyperalgesia in mouse with induced endometriosis.
    Sun Q; Ding D; Liu X; Guo SW
    Reprod Biol Endocrinol; 2016 Apr; 14():17. PubMed ID: 27062244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymoproteasome-Expressing Mesenchymal Stromal Cells Confer Protective Anti-Tumor Immunity
    Bikorimana JP; El-Hachem N; El-Kadiry AE; Abusarah J; Salame N; Shammaa R; Rafei M
    Front Immunol; 2020; 11():596303. PubMed ID: 33542714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysine-specific demethylase 1-mediated demethylation of histone H3 lysine 9 contributes to interleukin 1β-induced microsomal prostaglandin E synthase 1 expression in human osteoarthritic chondrocytes.
    El Mansouri FE; Nebbaki SS; Kapoor M; Afif H; Martel-Pelletier J; Pelletier JP; Benderdour M; Fahmi H
    Arthritis Res Ther; 2014 May; 16(3):R113. PubMed ID: 24886859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of lysine-specific demethylase 1 in ovarian endometriomas and its inhibition reduces cellular proliferation, cell cycle progression, and invasiveness.
    Ding D; Liu X; Guo SW
    Fertil Steril; 2014 Mar; 101(3):740-9. PubMed ID: 24388204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of tranylcypromine derivatives as novel LSD1/HDACs dual inhibitors for cancer treatment.
    Duan YC; Ma YC; Qin WP; Ding LN; Zheng YC; Zhu YL; Zhai XY; Yang J; Ma CY; Guan YY
    Eur J Med Chem; 2017 Nov; 140():392-402. PubMed ID: 28987602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structurally designed trans-2-phenylcyclopropylamine derivatives potently inhibit histone demethylase LSD1/KDM1 .
    Mimasu S; Umezawa N; Sato S; Higuchi T; Umehara T; Yokoyama S
    Biochemistry; 2010 Aug; 49(30):6494-503. PubMed ID: 20568732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional RIG-I-like receptors control the survival of mesenchymal stem cells.
    Yang K; Wang J; Xiang AP; Zhan X; Wang Y; Wu M; Huang X
    Cell Death Dis; 2013 Dec; 4(12):e967. PubMed ID: 24336087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of new tranylcypromine derivatives as highly potent LSD1 inhibitors.
    Huang MJ; Guo JW; Fu YD; You YZ; Xu WY; Song TY; Li R; Chen ZT; Huang LH; Liu HM
    Bioorg Med Chem Lett; 2021 Jun; 41():127993. PubMed ID: 33775841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD86 expression as a surrogate cellular biomarker for pharmacological inhibition of the histone demethylase lysine-specific demethylase 1.
    Lynch JT; Cockerill MJ; Hitchin JR; Wiseman DH; Somervaille TC
    Anal Biochem; 2013 Nov; 442(1):104-6. PubMed ID: 23911524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible LSD1 Inhibitors: Application of Tranylcypromine and Its Derivatives in Cancer Treatment.
    Zheng YC; Yu B; Jiang GZ; Feng XJ; He PX; Chu XY; Zhao W; Liu HM
    Curr Top Med Chem; 2016; 16(19):2179-88. PubMed ID: 26881714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of tranylcypromine analogs with an acylhydrazone substituent as LSD1 inactivators: Design, synthesis and their biological evaluation.
    Sun K; Peng JD; Suo FZ; Zhang T; Fu YD; Zheng YC; Liu HM
    Bioorg Med Chem Lett; 2017 Nov; 27(22):5036-5039. PubMed ID: 29037950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable H3 peptide was delivered by gold nanorods to inhibit LSD1 activation and induce human mesenchymal stem cells differentiation.
    Meng X; Li J; Zheng M; Zuo L; Sun C; Zhu Y; Fang L; Liu L; Zhou X
    Oncotarget; 2017 Apr; 8(14):23110-23119. PubMed ID: 28416745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors.
    Singh MM; Manton CA; Bhat KP; Tsai WW; Aldape K; Barton MC; Chandra J
    Neuro Oncol; 2011 Aug; 13(8):894-903. PubMed ID: 21653597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of lysine-specific demethylase LSD1 induces senescence in Glioblastoma cells through a HIF-1α-dependent pathway.
    Saccà CD; Gorini F; Ambrosio S; Amente S; Faicchia D; Matarese G; Lania L; Majello B
    Biochim Biophys Acta Gene Regul Mech; 2019 May; 1862(5):535-546. PubMed ID: 30951900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity studies on N-Substituted tranylcypromine derivatives lead to selective inhibitors of lysine specific demethylase 1 (LSD1) and potent inducers of leukemic cell differentiation.
    Schulz-Fincke J; Hau M; Barth J; Robaa D; Willmann D; Kürner A; Haas J; Greve G; Haydn T; Fulda S; Lübbert M; Lüdeke S; Berg T; Sippl W; Schüle R; Jung M
    Eur J Med Chem; 2018 Jan; 144():52-67. PubMed ID: 29247860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.